TRADIPITANT, A NOVEL NEUROKININ-1 RECEPTOR ANTAGONIST, SHOWED CONTINUED IMPROVEMENT IN NAUSEA AND OTHER SYMPTOMS ASSOCIATED WITH GASTROPARESIS IN AN OPEN-LABEL EXTENSION OF A PHASE II CLINICAL TRIAL
Jesse L. Carlin 1
Meredith S. Bagger 1
Darby S. Madonick 1
Caleigh Q. Kupersmith 1
Miren Lopez Lascurain 1
Changfu Xiao 1
Gunther Birznieks 1
Michaela Fisher 1
Mihael Polymeropoulos 1
1 Vanda Pharmaceuticals, Inc., Washington, United States
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]